The Raman spectra of the polyene antibiotic nystatin have been investigated between 1500 and 1650 cm-1. Only one band is observed in the resonance Raman spectra obtained with a 3045 A excitation radiation.
Polyene macrolide antibiotics interact with cell membranes and promote more or less important selective alterations of the membrane permeability leading to cell deaths'. The region of absorption of their polyene part, far from that of the lipid or protein molecules, as well as the large corresponding extinction coefficient make optical spectroscopies particularly appealing for the study of the interaction of these antibiotics with the membranes or their models. Among these methods, resonance or preresonance Raman scattering was used to study the interaction of amphotericin B2' and nystatin3' with phospholipid membrane models. The potential usefulness of this method requires, therefore, a good knowledge of the spectral characteristics of the antibiotics.
Nystatin is a tetraene and exhibits around 300 nm the vibronic absorption bands expected for a molecule containing 4 conjugated double bonds. The presence of supplementary weak bands around 400 nm, the intensity of which depends on the sample studied, may be attributed to the presence of the heptaene impurities commonly found in nystatin4-6). In this report we show that the resonance effect in Raman scattering can preferentially enhance the spectra of these impurities and perturb the nystatin spectra, the absorption domain of the heptaene being much nearer to the exciting laser radiation wavelength (4545 A) than that of nystatin.
Materials and Methods
Commercial nystatin samples were purified by chromatography according to FANG", employing a Waters HPLC system, an Altex Ultrasphere ODS column (5 ,um tronic absorption spectra were recorded with a Cary 219 spectrophotometer and circular dichroism (CD) spectra with a Jobin-Yvon Mark III dichrograph. Preresonance Raman spectra were recorded on a Coderg PH, double monochromator with EMI 95058 photomultiplier.
The spectra were excited with the line 4545 A of an argon ion laser (Spectra Physics 171). The laser power was approximately 190 mW. The Raman frequencies were calibrated to an accuracy of ±1 cm-1 and the split width was 3 cm-1. The experimental conditions were exactly the same as in ref 3. Resonance Raman spectra were recorded on a Jobin-Yvon Ramanor HG 2S under the conditions already described".
Results
Absorption and CD spectra in dimethyl sulfoxide (DMSO) in nystatin samples from various origins (sample 1, sample 2 and HPLC-purified samples) were recorded. It appeared that samples of identical absorption or CD in the 300-nm region, gave spectra of very different intensities in the 400-nm region although the maxima were located at the same wavelength, namely 417, 392 and 372 nm. The intensity was approximately divided by 10 when going from the commercially available products to the purified samples. Fig. 1 gives an example of such a variation. The absorption and CD spectra in Tris buffer pH 7.4 are concentration-dependent, at least for the 400-nm bands: when going from a 10-' M concentration in commercial nystatin to a 10-1 M concentration, the bands are shifted from 420, 394 and 374 to In Fig. 2 (I) we give an example of such a variation and in Fig. 3 we have plotted the ratios of the Raman peak heights at 1607 cm-1 and 1557 cm-1 as a function of the ratios of the electronic absorption peak heights at 416 nm and 309 nm for the different samples studied.
Resonance Raman spectra (3045 A excitation) of all the samples of nystatin studied exhibit only one
band between 1500 and 1650 cm-1 ( Fig. 2 (II) ).
Interpretation
In the previous nystatin Raman scattering study" the weak absorption bands near 400 nm were considered as originating from a 17-+17* 'Ag-->'Ag dipole-forbidden transition to an excited state involving a doubly excited configuration.
However, the energy difference between the lowest excited electronic states ('Ag* and 1Bu) in unsubstituted linear octatetraenes is 4495 cm-1 in methanol, or even less if a substituted tetraene is considered9) while in the observed spectra of nystatin the energy gap, in the same solvent, between the first of the strong bands (304 nm) and the first of the weak bands (405 nm) is 8200 cm-1
As on the other hand, the intensity of the weak bands depends on the origin of the sample, and their wavelength region is that of heptaenes, we think that the origin of the weak bands is to be found in heptaene impurities, the presence of which was already demonstrated'-').
The expected a in DMSO is therefore about 105, from which it can be inferred that the impurities account for approximately 2 % of the commercial products.
This would explain the concentration dependence of the nystatin absorption spectra in aqueous buffer: when going from 10-4 M to 10-5 M in commercial nystatin, namely 5 x 10-6 to 5 x 10-7 M in im- 1985 purity, the weak bands are blue shifted while the location of the strong bands is invariant. As a matter of fact above 10-6 M the polyene antibiotics in aqueous solvents are generally in selfassociated form while below they are present as monomers. Therefore, when going from 10-" M to 10-1m, nystatin remains in a self-associated form or a heptaene-tetraene associated form while this is not the case for the impurity.
As for the purified nystatin, the amount of impurity is such that it is always in monomeric form and absorbs at 410, 385 and 366 nm. From the absorption wavelength in 95 ethanol (408, 384 and 364 nm) some candidates may be proposed as representing the impurity: amphotericin B, candidin, perimycin and candimycin, the other heptaenes absorbing at different wavelengths"'. Amphotericin B may be eliminated because the corresponding intense excitonic doublet normally found in aqueous buffer11) is not observed here. Candidin may be the impurity because it is chemically closely related to nystatin and is susceptible to being co-produced with nystatin1z12) The nystatin Raman spectra are easily interpreted in terms of this impurity. In the resonance Raman spectra of the linear polyenes, two strong bands are observed"): one corresponds to the C=C stretching near 1500-1600 cm-1and another at 1150-1200 cm-1results from the admixture of C-C and C=C stretching with C-H bending. The frequency of v (C=C) depends on the number of double bonds and decreases as the chain becomes progressively longer. In contrast, the frequency of the bands around 1150 1200 cm-1is invariant. From the relationship obtained from the plot of v (C=C) against the number of double bonds13), v (C=C) is expected to be around 1600 cm-1in tetraenes and 1550 cm-1in heptaenes.
Indeed in the resonance Raman spectra (3045 A excitation) we observe one band between 1500 and 1650 cm-1at 1610 cm-'. On the other hand, in the preresonance condition in which the spectra are obtained, the Raman spectrum of the heptaene impurity is expected to be much more enhanced by resonance than that of nystatin, the wavelengths of absorption of the heptaenes being much nearer to that of the exciting radiation (4545 A) than that of the tetraenes. For this reason, even if the heptaene represents only 2% of the commercial nystatin, it is possible to observe its spectrum superimposed on that of nystatin, and the band at 1557 cm-1corresponds to v (C=C) of the heptaene and the band at 1607 cm-1to v (C=C) of the tetraene nystatin. In purified nystatin the band at 1557 cm-1is much less intense, as expected. The band observed at 1632 cm-1has been tentatively assigned to v (C=O) as in the case of amphotericin B13). In conclusion it appears that the only difference between the Raman spectra of pure nystatin and that of amphotericin B is the expected shift of v (C=C).
No confirmation of the proposed existence3) of two nystatin conformers can be obtained from v (C=0) consideration. 
